Less common concerns include gallstones, a small rise in pancreatitis risk, semaglutide muscle loss during rapid weight loss, and cosmetic effects such as hair loss and facial volume loss (sometimes called Ozempic face)
Indeed, in our first on-treatment analysis at week 208, weight loss was greater (11.7% for semaglutide) compared with the in-trial analysis (10.2% for semaglutide)
The FDA does not require pre-market approval for cosmetic ingredients the way it does for drugs, so a topical GHK-Cu product can be sold legally as a cosmetic without being an "FDA-approved" drug
A., Nicora, R., Ashbrook, D., and Kopple, J
2015;16(suppl 1):7790
The total weight lost over six months tends to be similar whether someone escalates aggressively or conservatively, because the aggressive escalator often has to pause or reduce doses due to side effects while the conservative escalator progresses steadily without interruption